Calyx partners with Neosoma on AI advancement

By staff writers

November 17, 2022 -- Calyx Medical Imaging is partnering with Neosoma to advance that company's high-grade glioma (HGG) artificial intelligence (AI)-based neuro-oncology software, Neosoma HGG.

Neosoma HGG uses AI to measure tumor volume on brain MRI exams. The device was granted 510(k) clearance by the U.S. Food and Drug Administration in October.

Calyx said this partnership will extend to other AI-based technologies Neosoma is developing.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking